Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFAMOSTAT for Anticoagulant therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where NAFAMOSTAT was used for Anticoagulant therapy.

Most Reported Side Effects for NAFAMOSTAT

Side Effect Reports % Deaths Hosp.
Off label use 29 30.9% 3 13
Drug ineffective 11 11.7% 1 5
Anaphylactic shock 7 7.5% 0 4
Covid-19 7 7.5% 2 5
Hypotension 6 6.4% 3 6
Tremor 6 6.4% 0 0
Acute respiratory distress syndrome 5 5.3% 3 3
Diarrhoea 5 5.3% 3 2
Disseminated intravascular coagulation 5 5.3% 3 3

Other Indications for NAFAMOSTAT

Covid-19 (25) Product used for unknown indication (17) Covid-19 pneumonia (8)

Other Drugs Used for Anticoagulant therapy

SODIUM (6,795) HEPARIN (3,476) WARFARIN (3,055) RIVAROXABAN (2,573) ASPIRIN (2,154) ENOXAPARIN (1,439) CLOPIDOGREL BISULFATE (1,340) APIXABAN (1,275) DABIGATRAN ETEXILATE (780) PRADAXA (418)

Related Pages

NAFAMOSTAT Full Profile All Anticoagulant therapy Drugs NAFAMOSTAT Demographics NAFAMOSTAT Timeline